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Abstract
The ability of peripheral nervous system neurons to extend long, axon-like neurites in vitro makes them
ideally suited for studies on mechanisms of axon survival and degeneration. In this chapter, we describe how
to prepare explant cultures of sympathetic neurons of the superior cervical ganglion (SCG). We also
describe how to induce and assess axon degeneration with an injury or a chemical insult.
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1 Introduction
Axon loss is an early feature of several neurodegenerative disorders
and leads to compromised neuronal function. Understanding how
axons die is important to identify therapeutic targets to delay or halt
the progression of these pathologies [1]. Much of the current
knowledge on mechanisms of axon degeneration comes from stud-
ies in primary neuronal cultures of sympathetic superior cervical
ganglion (SCG) and sensory dorsal root ganglion (DRG) neurons.
This chapter focuses on how to culture and assess neurite
(axon) degeneration in SCG explant cultures from postnatal mice.
Explant cultures offer a number of advantages when assessing axon
degeneration. These are relatively easy to dissect and culture since
plating of the whole ganglia avoids complications and variability
due to dissociation protocols. Neuronal cell bodies are located
within the ganglion, with long axon-like neurites (5–6 mm long
at 7 days in vitro, DIV) radially extending away from it; this hugely
simplifies experiments of axon degeneration following an injury
since all neurites distal to the site of injury are transected (Fig. 1).
Furthermore, directly comparable areas of neurites (e.g., the distal
ends) can be imaged over time across different dishes and
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Fig. 1 Representative images of uninjured and injured SCG explant cultures. (a) Representative phase-contrast
image of a SCG explant at 7 DIV. Long neurites have extended radially from the ganglion. Different types of
transection can be performed: (b) A short transection permits a side-by-side comparison of cut and uncut
neurites. (c) Transection of all the neurites on one side of the dish avoids overlapping of uncut and cut neurites
and increases the area of degenerating neurites that can be imaged. (d) Transection of all neurites to
maximize the area of degenerating neurites to image (see Note 11). (e) Representative phase-contrast
images of healthy and degenerating neurites
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experimental conditions. Finally, several neurites are imaged at the
same time, minimizing differences in the time of degeneration of
individual neurites and facilitating quantification of the extent of
degeneration.
In this chapter, we describe two methods to induce neurite
degeneration: (1) the injury model, where degeneration is initiated
by a physical transection of the neurites, a process known as Waller-
ian degeneration, and (2) chemically induced degeneration, where
neurite death is caused by the administration of a toxic compound
to uninjured neurons. The most widely used toxic compounds to
induce neurite degeneration are chemotherapy agents such as vin-
cristine, the mitochondrial toxins Carbonyl cyanide m-chlorophe-
nyl hydrazone (CCCP), and rotenone and inhibitors of protein
synthesis such as cycloheximide and emetine [2–5]. Interestingly,
all these drugs initiate an axon death program that is mechanisti-
cally related to Wallerian degeneration. Quantification of neurite
degeneration can be easily performed through analysis of phase-
contrast images with an ImageJ plugin to give a degeneration index
score [6]. This method allows images to be acquired from the same
culture at different timepoints, so that morphological changes
occurring to the same group of neurites can be followed over
time. Alternatively, neurite morphology can be visualized by immu-
nostaining with antibodies against neuronal and axonal markers,
although this requires cultures to be fixed, so a separate dish is
needed for each timepoint. Not only does this preclude following
changes in the same group of neurites, but it also means that a
greater number of cultures are needed for every experiment.
Importantly, although not detailed here, the transection
experiments described in this chapter can also be used to provide
material from the cell body and neurites separately for biochemical
and protein expression studies [2, 7, 8]. Finally, although this
chapter is specific for mouse SCG explant cultures, similar methods
can also be applied to rat SCG and mouse/rat DRG explant
cultures.
2 Materials
Preparation of solutions should be performed in a laminar flow
cabinet or Class II biological safety cabinet.
2.1 Dissection
and Plating of SCG
Explant Cultures
1. No. 5 forceps and microdissection scissors sterilized in 70%
ethanol and air-dried before use.
2. Leibovitz’s L-15 medium (with L-glutamine). Store at 4 C.
3. SCG medium: Dulbecco’s Modified Eagle Media (DMEM)
(with 4500 mg/l glucose and 110 mg/l sodium pyruvate)
supplemented with 10% fetal bovine serum (FBS) or 2% B27
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(see Note 1), 1 penicillin/streptomycin, 2 mM L-glutamine,
4 μM aphidicolin, and 25–50 ng/ml 2.5S nerve growth factor
(NGF) or 100 ng/ml 7S NGF (see Note 2). A stock of 50 ml
(or more) of SCG medium containing DMEM, FBS or B27,
penicillin/streptomycin, and L-glutamine can be stored at 4 C
for up to 3 weeks. Aphidicolin and NGF should always be
added fresh to the required amount of medium. Concentrated
stock solutions of each supplement are as follows: 100 peni-
cillin/streptomycin (10,000 U/ml penicillin and 10,000 μg/
ml streptomycin in 10 mM citrate buffer); 100 L-glutamine
(200 mM); 4 mM aphidicolin in DMSO; and 100 μg/ml 2.5S
or 7S NGF prepared following the manufacturer’s instructions.
Aliquots of each supplement are stored at 20 C.
4. Sterile 35 mm tissue culture dishes.
5. Solutions for coating of tissue culture dishes: 20 μg/ml poly-L-
lysine (Mw 300,000) hydrobromide in sterile, tissue culture-
grade water and 20 μg/ml laminin in DMEM (980 μl DMEM
per 20 μl laminin aliquot). Do not use SCG medium to dilute
the laminin as the presence of FBS will interfere with coating.
Concentrated stock solutions of each supplement are as fol-
lows: 2.5 mg/ml poly-L-lysine stock solution (125) in sterile,
tissue culture-grade water and 1 mg/ml laminin, stored as
20 μl aliquots in 1.5 ml microfuge tubes. Aliquots of each
supplement are stored at 20 C.
6. Sterile, disposable blades for attachment to a nondisposable
scalpel handle or sterile disposable surgical scalpels with a poly-
styrene handle. Blades should be curved with a relatively long
cutting edge (e.g., No. 10 or No. 22).
3 Methods
All steps are performed at room temperature in a horizontal laminar
flow cabinet unless indicated otherwise.
3.1 Dissection
and Culture of SCG
Explants
1. To coat the dishes, add 1 ml of poly-L-lysine hydrobromide
solution to cover the whole surface of a 35-mm sterile tissue
culture dish and incubate for at least 1 h at room temperature.
Next, remove the poly-L-lysine solution and wash the dish
twice with sterile water before leaving to air dry completely.
Dried poly-L-lysine-coated dishes can be stored at 4 C
wrapped in parafilm for several weeks. Add ~200–250 μl of
the laminin solution to coat a circular area, approximately
20 mm in diameter, in the center of each dish (see Note 3).
Incubate for 1–2 h at room temperature or in a 5% CO2
incubator at 37 C. Remove the laminin solution and immedi-
ately add 600 μl of SCGmedium to cover the whole surface of a
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35-mm tissue culture dish before plating of ganglia. The
laminin-coated area should not be allowed to dry.
2. Dissect superior cervical ganglia from 0- to 3-day-old mice (see
Note 4) using a stereoscopic microscope, sterilized
No. 5 forceps, and microdissection scissors. Decapitate mice
using sharp scissors, which must be positioned behind the ears
to avoid accidental removal of the ganglia. Pin the head to a
Syligard-coated dish, and remove excessive tissue and trachea
to expose the ganglia. These are located at the point where the
carotid artery bifurcates into the internal and external carotid
arteries. The SCG has a distinctive oval shape and appears
white/translucent compared to surrounding tissue (Fig. 2).
Care should be taken to distinguish the SCG from the nodose
ganglion, which is also located close the carotid artery branch
point. The nodose ganglion is smaller and attached to a thicker
nerve fiber. Transfer the dissected ganglia in a 35-mm sterile
tissue culture dish filled with Leibovitz’s L-15 medium (see
Note 5).
Fig. 2 Dissection of SCG explants. (a and b) Excessive fat tissue (green arrow) and trachea (white arrow) are
removed to expose the ganglia. (c) The two SCG explants (white arrows) have a distinctive oval shape and
appear white/translucent compared to surrounding tissue. (d) Uncleaned SCG soon after dissection. (e) Clean
SCG ready to be plated
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3. Use forceps to gently remove any associated nerve fibers and
extraneous tissue (see Note 6). Transfer cleaned SCG explants
to another 35 mm dish filled with Leibovitz’s L-15 medium.
4. Plate two-to-three ganglia in the center of the tissue culture
dish filled with 600 μl of SCG medium (see Note 7), and
transfer the dishes to a 5% CO2 incubator at 37
C overnight.
If litters of mixed genotypes are being processed, two ganglia
from an individual mouse can be plated in the same dish to
ensure that explants deriving from mice with different geno-
types are kept separate.
5. The day after plating, check that ganglia are attached and that
neurites have extended radially (they should be several hundred
microns long by this stage). Carefully flood the dishes with 1ml
of SCG medium prewarmed to 37 C. Replace medium every
2–3 days with 1–2 ml of fresh SCG medium prewarmed to





1. Injury-induced degeneration assay: Perform transection using
an inverted microscope with a 2.5 or 5 objective under
transmitted light. Position the sterile scalpel blade, and cut by
rolling the cutting edge of the blade along the surface of the
dish with a single down-and-up movement. Bring the blade
back to its tip before removing it from the dish to avoid
accidental detachment of the neurite network caused by slip-
page of the blade (see Note 9). Keep the DIV at which the
cultures are manipulated consistent across dishes and experi-
ments to decrease variability in the timing of degeneration (see
Note 10). Different types of transection can be performed
(Fig. 1) (see Note 11).
2. Chemically induced degeneration assay: Replace the medium
with fresh SCG medium containing the compound of interest
(or vehicle) at the desired concentration. The concentration
should be determined by performing dose-response experi-
ments (see Note 12).
3. Quantification of neurite degeneration: Acquire phase-contrast
images of neurites using 10 or 20 objectives. The degener-
ation index can be calculated using the ImageJ plugin refer-
enced in the introduction of this chapter (see also Chapter 4).
The parameters of the plugin should be adjusted for the objec-
tive used and/or the resolution of the image. It is advisable to
image the distal ends where the neurite network is less dense
(see Note 13). Always capture a 0-h timepoint; subsequent
timepoints will depend on the type of insult applied (see Note
14). Ideally, the same field of neurites should be imaged at each
timepoint. Intact neurites will retain continuity, whereas the
appearance of blebs and fragmentation are indicators of degen-
eration (Fig. 1e).
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4 Notes
1. Other sources of FBS can be used but should first be tested
rigorously for their ability to maintain healthy cultures. Differ-
ent lots of FBS from the same source can also vary in their
quality. B27 supplement can also be used. While neurite mor-
phology differs slightly when FBS or B27 are used, they
respond similarly in degeneration assays. Culture quality can
be assessed by checking morphology of the neurites which
should look free from blebs, form a dense network and reach
5–6 mm length at 7 DIV.
2. Aphidicolin is used as an antimitotic to limit proliferation of
nonneuronal cells. A combination of 20 μM fluorodeoxyuri-
dine and 20 μM uridine can be used as an alternative to aphi-
dicolin but is less potent. 7S and 2.5S NGF can be obtained
from a number of commercial sources. SCG neurons require
NGF to survive; too low or too high concentrations in the
medium will result in unhealthy cultures. It is therefore critical
to determine empirically the optimal concentration to use. A
comparison of batches from different sources is advisable.
3. We recommend starting the coating procedure (which takes
2.5–3 h) before the dissection of SCG explants, so that the
ganglia can be cultured as soon as possible after dissection. It is
important that the dishes are fully dried after the poly-L-lysine
coating to avoid that the laminin solution spreads across the
whole dish surface (to limit the amount of laminin
solution used).
4. The age of the mouse pups can influence the growth character-
istics of the neurites, so this should be as closely matched as
possible.
5. Although not essential, it is advisable to keep mouse heads on
ice and to use cold L-15 medium, if the dissection procedure is
protracted. Mouse heads can be kept on ice for up to 4 h and
SCG ganglia can be stored in L-15 medium for up to 2 h at
4 C before plating, if required.
6. Some SCG explants might get damaged during the dissection
and cleaning procedures, but in most cases, incomplete ganglia
will survive and grow normally in culture and can be used.
7. SCG explants are plated in the center of a 35-mm dish contain-
ing 600 μl of SCG medium (this should be added immediately
after laminin is removed, see step 1) to promote attachment and
growth. This volume of SCG medium is enough to keep the
surface of the dish from drying out overnight in the incubator
but small enough that the ganglia are held in the center of the
dish by the surface tension. Care should be taken when
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transferring dishes to the incubator to avoid ganglia moving
from the center dish. The volume will have to be adapted if
dishes of different size are used. Plating two-to-three ganglia
per dish will increase internal variability and reliability of the
experiments, and plating explants close to each other simplifies
neurite transection. Do not prewarm the SCG medium if the
ganglia are kept in cold L-15 medium during the dissection
procedure (see Note 5).
8. It is important to add SCG medium within 16–24 h after
plating to prevent cultures from drying out. Care should be
taken when medium is added to SCG explant cultures or dishes
are moved out of the incubator since ganglia can detach. To
avoid this, gently add a couple of small drops of medium
directly over the ganglia before adding the remaining medium
to the side of the dish. For subsequent medium changes, always
remove old medium and add fresh medium slowly to the side of
the dish.
9. Great care should also be taken when moving dishes after
introducing the cut as transected/degenerating neurites are
more prone to detach from the dish surface.
10. Although injury experiments can be performed at any time
from 2 DIV, more consistent results are obtained between
5 and 7 DIV, when neurites reach the optimal length for
transection. Neurites cut between 5 and 7 DIV consistently
degenerate within 6–8 h after injury.
11. A short transection (Fig. 1b) permits a side-by-side comparison
of cut and uncut neurites, but it is important to note that intact
neurites at the edges of the cut might overlap with injured,
degenerating neurites. A field of neurites distant from the edge
of the cut should thus be selected if a quantification of degen-
eration of the transected neurites is performed. Transection of
all the neurites on one side of the dish (Fig. 1c) avoids this
problem and increases the area of degenerating neurites that
can be imaged. However, this type of transection increases the
chances of detachment of the neurite network. Finally, transec-
tion of all neurites can be performed (Fig. 1d) to maximize the
area of degenerating neurites, particularly, when collecting
material for biochemical and/or protein analyses, although an
internal uncut control will be lacking.
12. Concentrations of the most commonly used agents that cause
degeneration of SCG neurites: 20 nM vincristine, 50 μM
CCCP, 10 μM rotenone, 10 μg/ml cycloheximide, and
10 μM emetine. The time course of degeneration following
these treatments is generally slower than that of transected
neurites (6–8 h after injury at 5–7 DIV), the former normally
degenerate between 12 and 24 h after drug addition. The
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length of time in culture and culturing conditions might
impact on the degeneration time course. Most compounds
used to induce neurite degeneration are dissolved in DMSO.
To avoid any unwanted toxicity, it is preferable that the final
concentration of DMSO in the medium does not exceed 0.5%.
13. When quantifying the degeneration index using the ImageJ
plugin, the most reliable results are obtained when exactly the
same field of neurites is imaged at each timepoint with the
quality of images being as consistent as possible (especially
background signal).
14. Once the time of degeneration for a specific experimental
condition is determined, reduce the timepoints acquired to
minimize movement of the dishes out of the incubator and
prevent detachment of degenerating neurites. The highest
degeneration index score can be assigned to neurites that
fully detach from the dish. However, this should only be
done when degeneration could be documented in the previous
timepoint as dish movements can make transected neurites
detach at early timepoints even without degeneration. If neur-
ites have detached before degeneration has been seen, they
should be excluded from the analysis.
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